Fund Holdings — Vestal Point Capital, LP

Total Portfolio Value:
$1.27B
Total Bought:
$479.33M
Total Sold:
$561.85M
Net Transaction:
-$82.52M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)750,0001,600,000+850,000$50.25M$116.80M9.22%+$66.55M
Jazz Pharmaceuticals plcSHS USD(JAZZ)1,500,000900,000-600,000$160.09M$100.27M7.91%-$59.83M
Cytokinetics, Incorporated(CYTK)2,075,0001,500,000-575,000$112.42M$79.20M6.25%-$33.22M
Inari Medical Inc350,0001,550,000+1,200,000$16.85M$63.92M5.04%+$47.07M
Arcellx Inc
COMMON STOCK
675,000675,0000$37.25M$56.37M4.45%+$19.12M
Structure Therapeutics IncADS560,0001,150,000+590,000$21.99M$50.47M3.98%+$28.48M
KalVista Pharmaceuticals Inc2,300,0004,000,000+1,700,000$27.09M$46.32M3.65%+$19.23M
Astria Therapeutics Inc3,250,0004,000,000+750,000$29.57M$44.04M3.47%+$14.46M
Immatics N.V.SHS(IMTX)2,750,0003,750,000+1,000,000$31.95M$42.79M3.38%+$10.83M
Ultragenyx Pharmaceutical Inc.(RARE)1,800,000750,000-1,050,000$73.98M$41.66M3.29%-$32.32M
Ascendis Pharma A/SADR(ASND)750,000250,000-500,000$102.28M$37.33M2.95%-$64.96M
Soleno Therapeutics Inc1,200,000720,000-480,000$48.96M$36.35M2.87%-$12.61M
Day One Biopharmaceuticals Inc
COM
1,250,0002,500,000+1,250,000$17.23M$34.83M2.75%+$17.60M
Savara Inc.(SVRA)6,490,0008,090,000+1,600,000$26.15M$34.30M2.71%+$8.15M
Agios Pharmaceuticals, Inc.(AGIO)0760,000+760,000$0$33.77M2.66%+$33.77M
Xenon Pharmaceuticals Inc.(XENE)525,000825,000+300,000$20.47M$32.48M2.56%+$12.01M
BioMarin Pharmaceutical Inc.(BMRN)0400,000+400,000$0$28.12M2.22%+$28.12M
uniQure N.V.SHS(QURE)4,750,0004,750,0000$21.28M$23.42M1.85%+$2.14M
Janux Therapeutics, Inc.(JANX)725,000485,000-240,000$30.37M$22.03M1.74%-$8.34M
Black Diamond Therapeutics Inc2,100,0005,028,500+2,928,500$9.79M$21.87M1.73%+$12.09M
Solid Biosciences Inc2,665,0002,800,000+135,000$15.11M$19.52M1.54%+$4.41M
Edwards Lifesciences Corp0275,000+275,000$0$18.15M1.43%+$18.15M
Gilead Sciences, Inc.(GILD)0200,000+200,000$0$16.77M1.32%+$16.77M
Liquidia Corporation(LQDA)1,830,0001,500,000-330,000$21.96M$15.00M1.18%-$6.96M
Agilent Technologies, Inc.(A)0100,000+100,000$0$14.85M1.17%+$14.85M
Bristol-Myers Squibb Company(BMY)500,000250,000-250,000$20.77M$12.94M1.02%-$7.83M
GSK plcADR(GSK)0300,000+300,000$0$12.26M0.97%+$12.26M
Bicara Therapeutics Inc0425,000+425,000$0$10.82M0.85%+$10.82M
Dianthus Therapeutics, Inc.(DNTH)600,000395,000-205,000$15.53M$10.82M0.85%-$4.71M
Crinetics Pharmaceuticals Inc0205,000+205,000$0$10.48M0.83%+$10.48M
iTeos Therapeutics Inc1,750,0001,025,000-725,000$25.97M$10.47M0.83%-$15.50M
Applied Therapeutics Inc5,430,0001,145,000-4,285,000$25.36M$9.73M0.77%-$15.63M
Nurix Therapeutics, Inc.(NRIX)500,000425,000-75,000$10.44M$9.55M0.75%-$885.3K
SanofiADR(SNY)0150,000+150,000$0$8.64M0.68%+$8.64M
Bruker Corporation(BRKR)0125,000+125,000$0$8.63M0.68%+$8.63M
Apogee Therapeutics Inc0136,500+136,500$0$8.02M0.63%+$8.02M
Zymeworks Inc.(ZYME)440,000615,000+175,000$3.74M$7.72M0.61%+$3.97M
Lexeo Therapeutics, Inc.(LXEO)840,000850,000+10,000$13.47M$7.68M0.61%-$5.79M
Tarsus Pharmaceuticals, Inc.(TARS)0230,000+230,000$0$7.56M0.60%+$7.56M
Alto Neuroscience, Inc.(ANRO)620,000650,000+30,000$6.63M$7.44M0.59%+$808.2K
Becton, Dickinson and Company(BDX)030,000+30,000$0$7.23M0.57%+$7.23M
Madrigal Pharmaceuticals, Inc.(MDGL)030,000+30,000$0$6.37M0.50%+$6.37M
Legend Biotech CorporationADS(LEGN)0125,000+125,000$0$6.09M0.48%+$6.09M
Fate Therapeutics, Inc.(FATE)2,000,0001,685,000-315,000$6.56M$5.90M0.47%-$662.5K
Lakefront Biotherapeutics NVADR(LKFT)180,000180,0000$4.46M$5.18M0.41%+$721.8K
UroGen Pharma Ltd.(URGN)0400,000+400,000$0$5.08M0.40%+$5.08M
Monte Rosa Therapeutics, Inc.(GLUE)890,000930,000+40,000$3.33M$4.93M0.39%+$1.60M
Geron Corporation(GERN)01,050,000+1,050,000$0$4.77M0.38%+$4.77M
Passage Bio, Inc.(PASG)6,052,0006,100,000+48,000$4.81M$4.27M0.34%-$536.5K
Allogene Therapeutics Inc2,200,0001,500,000-700,000$5.13M$4.20M0.33%-$926.0K
Prime Medicine, Inc.(PRME)450,0001,070,000+620,000$2.31M$4.14M0.33%+$1.83M
Ventyx Biosciences Inc1,315,0001,725,000+410,000$3.04M$3.76M0.30%+$722.9K
Zevra Therapeutics, Inc.(ZVRA)0525,000+525,000$0$3.64M0.29%+$3.64M
Ardelyx Inc0500,000+500,000$0$3.44M0.27%+$3.44M
PTC Therapeutics, Inc.(PTCT)90,00080,000-10,000$2.75M$2.97M0.23%+$215.8K
Penumbra, Inc.(PEN)015,000+15,000$0$2.91M0.23%+$2.91M
Voyager Therapeutics, Inc.(VYGR)600,000490,000-110,000$4.75M$2.87M0.23%-$1.88M
MacroGenics, Inc.(MGNX)800,000830,000+30,000$3.40M$2.73M0.22%-$669.3K
Verve Therapeutics Inc500,000525,000+25,000$2.44M$2.54M0.20%+$101.0K
Intra-Cellular Therapies Inc030,000+30,000$0$2.20M0.17%+$2.20M
Establishment Labs Holdings Inc.(ESTA)040,000+40,000$0$1.73M0.14%+$1.73M
Relmada Therapeutics, Inc.(RLMD)1,200,000490,000-710,000$3.60M$1.59M0.13%-$2.01M
Achilles Therapeutics PLCADS1,500,0001,500,0000$1.22M$1.53M0.12%+$307.5K
Reneo Pharmaceuticals Inc545,000799,400+254,400$823.0K$1.36M0.11%+$536.0K
Chimerix Inc1,400,0001,400,0000$1.23M$1.30M0.10%+$75.6K
Atara Biotherapeutics Inc112,000124,677+12,677$952.0K$1.01M0.08%+$61.6K
Tenax Therapeutics, Inc.(TENX)083,333+83,333$0$288.3K0.02%+$288.3K
ALX Oncology Holdings Inc.(ALXO)3,600,0000-3,600,000$21.71M$0—-$21.71M
Apellis Pharmaceuticals Inc
COM
335,0000-335,000$12.85M$0—-$12.85M
Axsome Therapeutics, Inc.(AXSM)300,0000-300,000$24.15M$0—-$24.15M
BeOne Medicines AGADR(ONC)350,0000-350,000$49.93M$0—-$49.93M
BioNTech SEADS(BNTX)100,0000-100,000$8.04M$0—-$8.04M
Denali Therapeutics Inc.(DNLI)500,0000-500,000$11.61M$0—-$11.61M
Dyne Therapeutics, Inc.(DYN)225,0000-225,000$7.94M$0—-$7.94M
Endeavour Silver Corp.(EXK)925,0000-925,000$39.08M$0—-$39.08M
Fulcrum Therapeutics, Inc.(FULC)1,160,0000-1,160,000$7.19M$0—-$7.19M
Globus Medical, Inc.CL A(GMED)900,0000-900,000$61.64M$0—-$61.64M
Immunome, Inc.(IMNM)1,000,0000-1,000,000$12.10M$0—-$12.10M
Inspire Medical Systems, Inc.(INSP)60,0000-60,000$8.03M$0—-$8.03M
Iovance Biotherapeutics, Inc.(IOVA)300,0000-300,000$2.41M$0—-$2.41M
Newamsterdam Pharma Co NV
ORDINARY SHARES
25,0000-25,000$480.3K$0—-$480.3K
Pacira BioSciences, Inc.(PCRX)280,0000-280,000$8.01M$0—-$8.01M
Praxis Precision Medicines, Inc.(PRAX)440,0000-440,000$18.20M$0—-$18.20M
Page 1 of 1
Vestal Point Capital, LP — 13F Holdings — Q3 2024 | TickerTrail